At Mileutis, we are dedicated to the discovery, development, and commercialization of safe and residue-free therapies for animal health. Our mission is to contribute to humanity's quest for healthier lives through innovation. With a focus on antimicrobial resistance and reducing the overuse of antibiotics, our technology utilizes natural peptides that have a proven safety profile and broad therapeutic applicability.

These peptides work through an immune-modulatory effect, enabling the management of infectious and chronic diseases without antibiotics. Our leading products, Imilac™ and Milac™, are antibiotic-free and hormone-free biopharmaceuticals. Imilac™ is administered at the beginning of the dry-off period, while Milac™ is given during lactation.

These revolutionary products are set to transform the way veterinarians treat diseases such as clinical and subclinical mastitis, replacing the need for antibiotics on dairy farms. They not only improve the cows' well-being but also provide significant economic value to farmers by increasing milk yield and profitability. We are also actively developing additional products utilizing our residue-free immunomodulatory platform with casein-derived peptides.

At Mileutis, we are committed to making a positive impact on animal health and the global fight against antimicrobial resistance